Clinical Report: Reflections on Lumenis Accelerate from Laura Periman, MD
Overview
Dr. Laura Periman discusses key takeaways from the Lumenis Accelerate Owner’s Summit, focusing on advancements in dry eye disease management through OptiLight and OptiLift technologies.
Background
The management of dry eye disease is a significant concern in ophthalmology, particularly as it affects a large patient population. Recent advancements in technologies such as intense pulsed light (IPL) and dynamic muscle stimulation (DMSt) offer new avenues for addressing underlying anatomical and functional issues associated with dry eye.
Data Highlights
No numerical data provided in the source material.
Key Findings
- Attendees at the summit were primarily interested in expert management of dry eye disease.
- OptiLift technology utilizes radiofrequency and DMSt to address lid laxity and improve eyelid function.
- OptiLight and OptiLift technologies can be used sequentially to enhance treatment efficacy.
- Effective management of dry eye includes addressing inflammation, meibomian gland dysfunction, and lid muscle weakness.
Clinical Implications
The integration of OptiLift technology into practice allows clinicians to address complex dry eye conditions.
Conclusion
The Lumenis Accelerate Owner’s Summit provided insights into the application of advanced technologies for managing dry eye disease.
Related Resources & Content
- Optometric Management, Reflections on Lumenis Accelerate from Cory Lappin, OD, 2026 -- Reflections on Lumenis Accelerate from Cory Lappin, OD
- Optometric Management, Reflections on Lumenis Accelerate from Stacy Winter, 2026 -- Reflections on Lumenis Accelerate from Stacy Winter
- Optometric Management, Lumenis Accelerate, 2026 -- Lumenis Accelerate
- American Academy of Ophthalmology, Dry Eye Syndrome Preferred Practice Pattern®, 2023 -- Dry Eye Syndrome Preferred Practice Pattern®
- FDA, Correspondence Generator, 2021 -- FDA Classification of IPL for Dry Eye
- Frontiers, Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction, 2026 -- Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction
- optometric management — Lumenis Summit Offers Strategies for Building and Marketing Specialty Services
- Dry Eye Syndrome Preferred Practice Pattern® - Ophthalmology
- Correspondence Generator (CorGen)
- Frontiers | Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
- Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-A systematic review and meta-analysis - PubMed
- Safety and efficacy of a novel intense pulsed light system in patients with meibomian gland dysfunction: a randomized, double-masked, intra-individual controlled study | International Ophthalmology | Springer Nature Link
- Technological Interventions for Dry Eye Disease: A Systematic Review and Random-Effects Network Meta-analysis of 3-Month Outcomes | Ophthalmology and Therapy | Springer Nature Link
- Intense Pulsed Light (IPL) for Meibomian Gland Dysfunction | Clinical Review Criteria
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.